Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincenza Calvaruso

Showing results (1-10 of 120) with videos related to

Pageof 12
Sort By:
Gut|June 17, 2010
Hepassocin as a treatment for fulminant hepatic failure: will it translate from rats to human?Vincenza Calvaruso
Best Practice & Research. Clinical Gastroenterology|April 19, 2011
Fibrosis in chronic viral hepatitisVincenza Calvaruso, Antonio Craxì
Liver International : Official Journal of the International Association for the Study of the Liver|May 26, 2017
Hepatocellular carcinoma and direct-acting antivirals: A never ending story?Vincenza Calvaruso, Antonio Craxì
World Journal of Gastroenterology|January 1, 2014
Immunological alterations in hepatitis C virus infectionVincenza Calvaruso, Antonio Craxì
Journal of Viral Hepatitis|August 7, 2009
Implication of normal liver enzymes in liver diseaseVincenza Calvaruso, Antonio Craxì
Journal of Hepatology|August 11, 2020
Towards personalized screening for hepatocellular carcinoma: Still not thereVincenza Calvaruso, Jordi Bruix
Journal of Hepatology|December 21, 2020
Reply to: "Hepatic benefits of HCV cure: Don't forget coagulation!"Vincenza Calvaruso, Antonio Craxì
Journal of Hepatology|September 3, 2017
HBV recurrence after HCV clearance on DAAs: Sometimes they come backVincenza Calvaruso, Antonio Craxì
Journal of Hepatology|August 11, 2020
Hepatic benefits of HCV cureVincenza Calvaruso, Antonio Craxì
Liver International : Official Journal of the International Association for the Study of the Liver|January 5, 2016
Why do I treat my patients with mild hepatitis C?Vincenza Calvaruso, Antonio Craxì
Pageof 12

Showing results (1-10 of 120) with videos related to

Sort By:
Pageof 12
Gut|June 17, 2010
Hepassocin as a treatment for fulminant hepatic failure: will it translate from rats to human?Vincenza Calvaruso
Best Practice & Research. Clinical Gastroenterology|April 19, 2011
Fibrosis in chronic viral hepatitisVincenza Calvaruso, Antonio Craxì
Liver International : Official Journal of the International Association for the Study of the Liver|May 26, 2017
Hepatocellular carcinoma and direct-acting antivirals: A never ending story?Vincenza Calvaruso, Antonio Craxì
World Journal of Gastroenterology|January 1, 2014
Immunological alterations in hepatitis C virus infectionVincenza Calvaruso, Antonio Craxì
Journal of Viral Hepatitis|August 7, 2009
Implication of normal liver enzymes in liver diseaseVincenza Calvaruso, Antonio Craxì
Journal of Hepatology|August 11, 2020
Towards personalized screening for hepatocellular carcinoma: Still not thereVincenza Calvaruso, Jordi Bruix
Journal of Hepatology|December 21, 2020
Reply to: "Hepatic benefits of HCV cure: Don't forget coagulation!"Vincenza Calvaruso, Antonio Craxì
Journal of Hepatology|September 3, 2017
HBV recurrence after HCV clearance on DAAs: Sometimes they come backVincenza Calvaruso, Antonio Craxì
Journal of Hepatology|August 11, 2020
Hepatic benefits of HCV cureVincenza Calvaruso, Antonio Craxì
Liver International : Official Journal of the International Association for the Study of the Liver|January 5, 2016
Why do I treat my patients with mild hepatitis C?Vincenza Calvaruso, Antonio Craxì
Pageof 12